Bone Marrow Aspirate Concentrates Market Size & Share 2024 – 2032

Bone Marrow Aspirate Concentrates Market Size

Bone Marrow Aspirate Concentrates Market size was valued at around USD 172.8 million in 2023 and is anticipated to register a CAGR of over 5.4% between 2024 and 2032. Bone marrow aspirate concentrate (BMAC) is a form of regenerative therapy that involves harvesting a patient's own bone marrow, processing it to concentrate the stem cells and growth factors, and then injecting it into areas of the body where tissue repair or regeneration is needed. The increasing applications of BMAC is a significant driver for the market.

For instance, according to the published report in America Journal Roentgenology, in 2023, various studies have demonstrated significant improvements in pain, function, and outcomes for patients with knee osteoarthritis (OA) and osteochondral lesions. BMAC injections have shown to be effective in improving functional scores, reducing pain, and enhancing knee function in patients. Therefore, BMAC offers a minimally invasive, autologous (using the patient's own cells) treatment option with potentially quicker recovery times.
 

Furthermore, market growth is accredited to several factors, including the rising prevalence of orthopedic disorders, growing adoption of bone & joint health supplements, which is estimated to reach 26.4 billion by 2032, growing geriatric population, surging awareness and acceptance of regenerative medicine, and favorable regulatory environment.
 

Bone Marrow Aspirate Concentrates (BMAC ) Market Trends

Market expansion is anticipated to be propelled by the rising prevalence of orthopaedic disorders. BMAC offers a regenerative treatment option for these conditions, providing patients and healthcare providers with an alternative to traditional therapies.
 

• For instance, according to The World Health Organization (WHO), in 2023, approximately 1.71 billion people worldwide had musculoskeletal conditions.
   
• Similarly, according to the Centers for Disease Control and Prevention (CDC), among adults aged 45 to 64 years, one in four (26%) reported being diagnosed with arthritis, while among adults aged 65 years or older, almost half (47.3%) reported arthritis.
   
• Furthermore, with an active lifestyle and increased participation in sports, the incidence of fractures and trauma has risen. BMAC aids in bone healing and regeneration, accelerating the recovery process for patients with fractures."
   
• Conditions like degenerative disc disease, tendinitis, and bursitis are becoming more prevalent. Bone marrow aspirate concentrate has shown efficacy in treating these degenerative conditions by promoting tissue repair and reducing inflammation.
   

Bone Marrow Aspirate Concentrates Market Analysis

Based on product, the bone marrow aspirate concentrates market is bifurcated into bone marrow aspirate concentrates systems and bone marrow aspirate concentrates accessories. The bone marrow aspirate concentrates systems segment held the market size of USD 108.2 million in 2023.
 

• BMAC systems are designed to efficiently process bone marrow aspirate, separating it into its various components. This processing includes centrifugation or filtration to concentrate the stem cells, growth factors, and other bioactive molecules.
   
• Ongoing advancements in these systems have improved their efficiency, yield, and ease of use. Modern BMAC systems incorporate advanced technologies to optimize the processing and concentration of bone marrow aspirate.
   
• For instance, according to the National Library of Medicine, combining bone marrow aspirate concentrate systems with xenografts has shown advantages in achieving a higher mineralization pattern, making them a promising option for regenerative treatments.
   
• In orthopedics, BMAC systems are extensively used for procedures such as bone grafting, cartilage repair, and joint regeneration, thereby fostering the segment growth of the market.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on application, the bone marrow aspirate concentrates market is segmented into orthopaedic surgery, wound healing, peripheral vascular diseases, pain management, blood cancer, and other applications. The orthopaedic surgery segment is expected reach a market size of USD 81.3 million by 2032.
 

• Orthopedic conditions such as osteoarthritis, fractures, and sports injuries, are common and affect a significant portion of the population. The prevalence of these conditions drives the demand for effective BMAC treatment.
   
• For instance, according to The Times of India, in 2022, injury rates among young athletes have significantly increased over the last 10–15 years. Football and cricket players are experiencing a 500% increase in knee and ankle injuries, while there has been a 400% rise in anterior cruciate ligament (ACL) injuries.
   
• Furthermore, joint pain and osteoarthritis are major concerns for many individuals, particularly the aging population. BMAC injections into joints can reduce pain, improve function, and potentially delay the need for more invasive treatments like joint replacement surgery.
   
• Thus, patients prefer these less invasive options, leading to increased demand for BMAC in orthopedics, thereby stimulating the market’s growth.
   

Based on end-use, the bone marrow aspirate concentrates market is segmented into hospitals & clinics, pharmaceutical & biotechnology companies, CROs and CMOs, academic & research institutes, and other end-users. The hospitals & clinics segment held a market share of 35.3% in 2023.
 

• Hospitals and clinics are primary points of care for patients seeking orthopedic treatments, regenerative medicine, and other medical services. They serve a wide range of patients, including those with orthopedic conditions that benefit from BMAC therapies.
   
• These settings have access to advanced bone marrow aspirate concentrate systems and equipment for processing and administering BMAC. Consequently, they invest in state-of-the-art technologies to ensure efficient and effective procedures.
   
• Additionally, healthcare professionals in hospitals and clinics have the expertise and experience to perform these procedures safely and effectively. Orthopedic surgeons are well-versed in the applications for bone and tissue regeneration.
   

North America bone marrow aspirate concentrates market accounted for USD 70 million revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• The significant market share is correlated with the rising prevalence of orthopedic disorders, such as osteoarthritis and fractures, which are increasingly common in North America's aging population.
   
• For instance, according to a report by the American Society for Biochemistry and Molecular Biology (ASBMB), in 2022, osteoporosis is likely to be responsible for three million fractures resulting in USD 25.3 billion in costs annually by the end of 2025.
   
• "North America leads in clinical research and trials related to BMAC. Academic institutions and research centers in the region conduct studies to evaluate the efficacy and safety of bone marrow aspirate concentrate, further driving its adoption.
   

Bone Marrow Aspirate Concentrates Market Share

The bone marrow aspirate concentrates industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. Companies are developing innovative systems, components, and accessories to aid in the various application, such as orthopaedic surgery and wound healing. These bone marrow aspirate concentrates range from simple to advanced, reflecting the complex nature of various disorders. Regulatory approvals and collaborations with research institutions further influence market positioning.
 

Bone Marrow Aspirate Concentrates Market Companies

Some of the eminent market participants operating in the bone marrow aspirate concentrates industry include:

• Arthrex, Inc.
• Aspire Medical Innovation
• EmCyte Corporation
• Globus Medical, Inc.
• Isto Biologics
• MED & CARE - Innovative Solutions
• Ranfac Corporation
• Royal Biologics
• Scopio Labs
• Stryker Corporation
• Terumo Corporation
• Thermogenesis Holdings, Inc.
• Zimmer Biomet Holdings, Inc.
   

Phoropter Industry News:

• In June 2022, Royal Biologics received FDA 510(k) clearance for the MAXX-BMC system. The device has been designed for use in point-of-care settings to provide optimal samples of concentrated bone marrow aspirate (BMA) from a patient to users. This expansion of horizon within orthopedic and sports medicine surgical procedures has led to increased sales for the company.
   
• "In September 2022, Scopio Labs announced the launch of the Full-Field Bone Marrow Aspirate (FF-BMA) Application. This platform is the first to enable a complete digital workflow for bone marrow aspirate scanning and analysis. This addition to the product portfolio has resulted in increased sales for the company.
   

Bone marrow aspirate concentrates market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Bone marrow aspirate concentrates systems
• Bone marrow aspirate concentrates accessories

Market, By Application

• Orthopedic surgery
• Wound healing
• Peripheral vascular diseases
• Pain management
• Blood cancer
• Other applications

Market, By End-use

• Hospitals & clinics
• Pharmaceutical & biotechnology companies
• CROs and CMOs
• Academic & research institutes
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa